Skip to main navigation Skip to search Skip to main content

Autologous red cell agglutination assay for HIV-1 antibodies: Simplified test with whole blood

  • Bruce E. Kemp
  • , Dennis B. Rylatt
  • , Peter G. Bundesen
  • , Richard R. Doherty
  • , Dale A. Mcphee
  • , David Stapleton
  • , Louise E. Cottis
  • , Kim Wilson
  • , Michele A. John
  • , Julie M. Khan
  • , Denise P. Dinh
  • , Stephen Miles
  • , Carmel J. Hillyard

Research output: Contribution to journalArticleResearchpeer-review

Abstract

An antibody detection procedure based on agglutination of autologous red cells has been developed for samples of whole blood. A nonagglutinating monoclonal antibody to human red blood cells conjugated to a synthetic peptide antigen (in this case residues 579 to 601 of the HIV-1 envelope precursor, Arg-Ile-Leu-Ala-Val-Glu-Arg-Tyr-Leu-Lys-Asp-Gln-Gln-Leu-Leu-Gly-Ile-Trp-Gly-Cys- Ser-Gly-Lys) permitted the detection of antibodies to the human immunodeficiency virus type 1 (HIV-1) in 10 microliters of whole blood within 2 minutes. Agglutination was specifically inhibited by addition of synthetic peptide antigen but not by unrelated peptides. The frequency of false positive results was 0.1% with HIV-1 seronegative blood donors (n = 874). The false negative results were approximately 1% (n = 81). The autologous red cell agglutination test is potentially suitable for simple, rapid, qualitative screening for antibodies to a variety of antigens of medical and veterinary diagnostic significance.

Original languageEnglish
Pages (from-to)1352-1354
Number of pages3
JournalScience
Volume241
Issue number4871
DOIs
Publication statusPublished - 1 Jan 1988
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this